These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 19854437

  • 21. Ensemble feature selection: consistent descriptor subsets for multiple QSAR models.
    Dutta D, Guha R, Wild D, Chen T.
    J Chem Inf Model; 2007; 47(3):989-97. PubMed ID: 17407280
    [Abstract] [Full Text] [Related]

  • 22. Structure-activity relationships and binding mode in the human acetylcholinesterase active site of pseudo-irreversible inhibitors related to xanthostigmine.
    Rizzo S, Cavalli A, Ceccarini L, Bartolini M, Belluti F, Bisi A, Andrisano V, Recanatini M, Rampa A.
    ChemMedChem; 2009 Apr; 4(4):670-9. PubMed ID: 19222043
    [Abstract] [Full Text] [Related]

  • 23. Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimer's disease.
    Melchiorre C, Andrisano V, Bolognesi ML, Budriesi R, Cavalli A, Cavrini V, Rosini M, Tumiatti V, Recanatini M.
    J Med Chem; 1998 Oct 22; 41(22):4186-9. PubMed ID: 9784091
    [No Abstract] [Full Text] [Related]

  • 24. Receptor flexibility in de novo ligand design and docking.
    Alberts IL, Todorov NP, Dean PM.
    J Med Chem; 2005 Oct 20; 48(21):6585-96. PubMed ID: 16220975
    [Abstract] [Full Text] [Related]

  • 25. Lessons from functional analysis of AChE covalent and noncovalent inhibitors for design of AD therapeutic agents.
    Barak D, Ordentlich A, Kaplan D, Kronman C, Velan B, Shafferman A.
    Chem Biol Interact; 2005 Dec 15; 157-158():219-26. PubMed ID: 16289124
    [Abstract] [Full Text] [Related]

  • 26. Feature selection and linear/nonlinear regression methods for the accurate prediction of glycogen synthase kinase-3beta inhibitory activities.
    Goodarzi M, Freitas MP, Jensen R.
    J Chem Inf Model; 2009 Apr 15; 49(4):824-32. PubMed ID: 19338295
    [Abstract] [Full Text] [Related]

  • 27. QSARs and activity predicting models for competitive inhibitors of adenosine deaminase.
    Sadat Hayatshahi SH, Abdolmaleki P, Ghiasi M, Safarian S.
    FEBS Lett; 2007 Feb 06; 581(3):506-14. PubMed ID: 17250831
    [Abstract] [Full Text] [Related]

  • 28. Molecular dynamics simulation study and molecular docking descriptors in structure-based QSAR on acetylcholinesterase (AChE) inhibitors.
    Gharaghani S, Khayamian T, Ebrahimi M.
    SAR QSAR Environ Res; 2013 Feb 06; 24(9):773-94. PubMed ID: 23863115
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Homo- and hetero-bivalent edrophonium-like ammonium salts as highly potent, dual binding site AChE inhibitors.
    Leonetti F, Catto M, Nicolotti O, Pisani L, Cappa A, Stefanachi A, Carotti A.
    Bioorg Med Chem; 2008 Aug 01; 16(15):7450-6. PubMed ID: 18585045
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Discovery of a novel acetylcholinesterase inhibitor by structure-based virtual screening techniques.
    Chen Y, Fang L, Peng S, Liao H, Lehmann J, Zhang Y.
    Bioorg Med Chem Lett; 2012 May 01; 22(9):3181-7. PubMed ID: 22472693
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y, Iyarreta-Veitía M, Montero-Torres A, Romero-Zaldivar C, Brandt CA, Avila PE, Kirchgatter K, Machado Y.
    J Chem Inf Model; 2005 May 01; 45(4):1082-100. PubMed ID: 16045304
    [Abstract] [Full Text] [Related]

  • 35. Application of genetic algorithm-kernel partial least square as a novel nonlinear feature selection method: activity of carbonic anhydrase II inhibitors.
    Jalali-Heravi M, Kyani A.
    Eur J Med Chem; 2007 May 01; 42(5):649-59. PubMed ID: 17316919
    [Abstract] [Full Text] [Related]

  • 36. Molecular modelling, synthesis and acetylcholinesterase inhibition of ethyl 5-amino-2-methyl-6,7,8,9-tetrahydrobenzo[b][1,8]naphthyridine-3-carboxylate.
    Soriano E, Samadi A, Chioua M, de los Ríos C, Marco-Contelles J.
    Bioorg Med Chem Lett; 2010 May 01; 20(9):2950-3. PubMed ID: 20350807
    [Abstract] [Full Text] [Related]

  • 37. Molecular modeling, docking and ADMET studies applied to the design of a novel hybrid for treatment of Alzheimer's disease.
    da Silva CH, Campo VL, Carvalho I, Taft CA.
    J Mol Graph Model; 2006 Oct 01; 25(2):169-75. PubMed ID: 16413803
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Design, synthesis and evaluation of isaindigotone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Pan L, Tan JH, Hou JQ, Huang SL, Gu LQ, Huang ZS.
    Bioorg Med Chem Lett; 2008 Jul 01; 18(13):3790-3. PubMed ID: 18524585
    [Abstract] [Full Text] [Related]

  • 40. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
    Prado-Prado FJ, González-Díaz H, de la Vega OM, Ubeira FM, Chou KC.
    Bioorg Med Chem; 2008 Jun 01; 16(11):5871-80. PubMed ID: 18485714
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.